Array Analgesic Meets Primary, Secondary Endpoints In Phase II Pain Management Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Positive results from a second trial in post-surgical dental pain could lead to plans for broader indication.
You may also be interested in...
Array BioPharma Set To Raise Funds By Partnering Discovery Programs
Early partnering of preclinical glucokinase activator program would allow Array to stay focused on oncology and inflammation.
Array BioPharma Set To Raise Funds By Partnering Discovery Programs
Early partnering of preclinical glucokinase activator program would allow Array to stay focused on oncology and inflammation.
AstraZeneca/Array’s AZD6244 Fails Phase II For Melanoma
Firms enrolling patients for further trials of the drug candidate in ovarian cancer, hepatocellular and biliary tract carconomas.